financetom
Business
financetom
/
Business
/
Singapore Airlines CEO says travel out of China not yet recovered
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Singapore Airlines CEO says travel out of China not yet recovered
May 15, 2024 11:03 PM

SEOUL (Reuters) - Air travel demand from China is not back to pre-pandemic levels for Singapore Airlines, but a visa-free scheme for Chinese citizens to the Asian hub has helped fill seats and the airline will add more China capacity this year, its CEO said on Thursday.

Global aviation capacity returned to pre-pandemic levels this year, but recovery has been slower in Asia's aviation industry due to still-sluggish international demand in China, the world's second-largest economy.

"Travel into China has been strong, travel out of China has not yet recovered fully," Singapore Airlines CEO Goh Choon Phong told media.

He said the visa-free scheme between China and Singapore which began in February has provided "some lift to load factors" for Chinese flights.

The airlines group was progressively restoring China capacity and would increase seats to Shanghai, Beijing and Guangzhou this year, Phong added.

The flag carrier suspended April flights to China's Chengdu, Chongqing, and Xiamen, citing a lack of regulatory approvals. These are now in place and flights will operate until July, when permissions must be re-sought, Phong said.

Singapore Airlines posted a record annual profit for the second year in a row on Wednesday, raising its dividend.

However, the carrier's net profit fell around 4.5% year-on-year for the March quarter, with profit growth sliding in the preceding two quarters.

The company also expects passenger yields - a measure of average fare paid per mile, per passenger - to continue to moderate as airlines expand capacity, and flagged geopolitical woes and supply chain pressure.

SIA's shares were down 1.6% for the day at 13:30 pm (0430 GMT).

Singapore Airlines is set to take a 25.1% stake in Air India as a result of the Indian airline's merger with Vistara, its joint venture with Singapore Airlines. Phong said he was hoping to hear about regulatory approvals this year.

The airline has a current fleet of 200 aircraft, which it expects to rise to 209 this fiscal year. Phong said Singapore Airlines still expects a delivery of the Boeing 777-9 - a model yet to be certified by U.S. regulators - next year.

(Writing by Lisa Barrington; Editing by Janane Venkatraman)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Quantum Computing Receives NASA Contract for Data Optimization
Quantum Computing Receives NASA Contract for Data Optimization
Dec 17, 2024
09:05 AM EST, 12/17/2024 (MT Newswires) -- Quantum Computing ( QUBT ) said Tuesday it was awarded a contract by the National Aeronautics and Space Administration's Goddard Space Flight Center to use its Dirac-3 quantum optimization technology for image reconstruction and data analysis. Financial terms were not provided. The company said it will use its Dirac-3 system to address a...
Rocket Lab USA Says It Delivered Second Spacecraft for Varda
Rocket Lab USA Says It Delivered Second Spacecraft for Varda
Dec 17, 2024
09:02 AM EST, 12/17/2024 (MT Newswires) -- Rocket Lab USA ( RKLB ) said Tuesday it delivered a second spacecraft to Vandenberg Space Force Base and completed production of a third for Varda Space Industries under a four-spacecraft contract supporting in-orbit pharmaceutical manufacturing and reentry operations. The company said the Pioneer spacecraft, built by Rocket Lab, supports Varda's capsule, which...
MediPharm Labs Sells Napanee Facility to Kensana Health for $5.5 Million; Shares at 52 Week Lows
MediPharm Labs Sells Napanee Facility to Kensana Health for $5.5 Million; Shares at 52 Week Lows
Dec 17, 2024
09:07 AM EST, 12/17/2024 (MT Newswires) -- MediPharm Labs ( MEDIF ) on Tuesday entered into a share purchase agreement to sell all of its indirect equity interests in its unit ABcann Medicinals to Kensana Health for $5.5 million in cash. The company said pursuant to the deal, Kensana Health will buy the license, the building, land, and equipment associated...
Maiden Holdings to Divest Swedish Subsidiaries in All-Cash Deal
Maiden Holdings to Divest Swedish Subsidiaries in All-Cash Deal
Dec 17, 2024
09:03 AM EST, 12/17/2024 (MT Newswires) -- Maiden Holdings ( MHLA ) said Tuesday it has agreed to sell its Swedish subsidiaries, Maiden General Forsakrings and Maiden Life Forsakrings, to an unnamed London-based buyer. The all-cash deal is subject to regulatory approval and includes the transfer of all staff and independent directors of the subsidiaries to the new ownership group,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved